Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing iopamidol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopamidol (substance) |
Inferred relationship |
Some |
1 |
iopamidol 61,2% sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 150 mg (I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 200 mg (I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 300 mg (I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 340 mg (I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 370 mg(I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
Iopamidol 408mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
Iopamidol 200mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
Iopamidol 300mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
Iopamidol 370mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
Iopamidol 250mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg + iod 370 mg/ml (76%) injektionsvæske, opløsning, flaske a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg + iod 370 mg/ml (76%) injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 612 mg + iod 300 mg/ml (61%) injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + jod 370 mg/ml injektionsvæske, opløsning, flaske á 125 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg + iod 200 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg + iod 370 mg/ml (76%) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg + iod 200 mg/ml (41%) injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg + iod 370 mg/ml (76%) injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 510 mg + iod 250 mg/ml (51%) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg/ml + iod 200 mg/ml injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 612 mg + iod 300 mg/ml (61%) injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 510 mg + iod 250 mg/ml (51%) injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg + iod 200 mg/ml (41%) injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg + iod 370 mg/ml (76 %) injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + jod 370 mg/ml injektionsvæske, opløsning, hætteglas á 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 510 mg + iod 250 mg/ml (51%) injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg + iod 370 mg/ml (76%) injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg/ml + iod 200 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 510 mg + iod 250 mg/ml (51 %) injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml (76 %) injektionsvæske, opløsning, flaske a 175 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml (76%) injektionsvæske, opløsning, flaske a 125 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 612 mg + iod 300 mg/ml (61%) injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg + iod 370 mg/ml (76%) injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg/ml + iod 200 mg/ml injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 612 mg + iod 300 mg/ml (61%) injektionsvæske, opløsning, hætteglas a 15 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg + iod 200 mg/ml (41%) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg + iod 200 mg/ml (41%) injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 612 mg + iod 300 mg/ml (61%) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg/ml + iod 200 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 175 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 612 mg + iod 300 mg/ml (61%) injektionsvæske, opløsning, flaske a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 408 mg + iod 200 mg/ml (41 %) injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 150 mg (I)/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 150 mg (I)/ml injektionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 150 mg (I)/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 150 mg (I)/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 200 mg (I)/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 200 mg (I)/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 200 mg (I)/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 200 mg (I)/ml injektionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 300 mg (I)/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 300 mg (I)/ml injektionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 300 mg (I)/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 300 mg (I)/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 340 mg (I)/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 340 mg (I)/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 340 mg (I)/ml injektionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 340 mg (I)/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 370 mg(I)/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 370 mg(I)/ml injektionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 370 mg(I)/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
iopamidol 370 mg(I)/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
Iopamidol 61.2% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Some |
|
Product containing only iopamidol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopamidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely iodine (as iopamidol) 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iopamidol (substance) |
Inferred relationship |
Some |
1 |
Product containing iopamidol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopamidol (substance) |
Inferred relationship |
Some |
1 |
Product containing only iopamidol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopamidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely iodine (as iopamidol) 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iopamidol (substance) |
Inferred relationship |
Some |
1 |
Iodine (as iopamidol) 370 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iopamidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely iodine (as iopamidol) 340 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iopamidol (substance) |
Inferred relationship |
Some |
1 |